摘要
Abstract
Objective To observe the clinical efficacy and safety in the treatment of adenoidal hypertrophy by adenoid adenoidectomy. Methods Selected 110 cases of children with adenoidal hypertrophy as research subjects in our hospital from March 2009 to August 2012,they were randomly divided into treatment group (58 cases) treated with intranasal adenoidectomy under endoscope therapy and control group given conservative treatment (52 cases) according to the random number table, the clinical efficacy and adverse reactions were compared between the two groups. Results After treatment,the total effective rate in treatment group was significantly higher than that in control group (x2=11.053,P<0.01). The recurrence was compared between the two groups during six months of follow-up,1 case relapsed in treatment group, the recurrence rate was 1.7%;5 cases of recurrence in control group, the recurrence rate was 8.6%, the recurrence rate in treatment group was significantly higher than that in control group (x2=5.274, P < 0.05).2 cases of nasal bleeding in treatment group after operation, given 0.5% nasal ephedrine or 0.05%hydrochloric acid hydroxyl methyl thiazole moiety to stop bleeding after nasal drops;4 cases of nasal dryness in control group without other adverse reactions. Conclusion Endoscopic adenoidectomy in the treatment of children with adenoidal hypertrophy is safe and effective,should be widely applied.关键词
鼻内窥镜/腺样体肥大/腺样体切除术/疗效/安全性Key words
Nasal endoscope/Adenoidal hypertrophy/Adenoidectomy/Efficacy/Safety分类
医药卫生
